Given that the combination of oxaliplatin and 5-FU can inhibit DNA synthesis and transcription, thus leading to apoptosis, it is effective to target ENO1 to treat patients with advanced CRC with high levels of F. nucleatum [49,56,57]. This evidence concerns the gene ENO1 and colorectal carcinoma.